Cargando…
Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening
O-GlcNAcylation is an essential post-translational modification installed by the enzyme O-β-N-acetyl-d-glucosaminyl transferase (OGT). Modulating this enzyme would be extremely valuable to better understand its role in the development of serious human pathologies, such as diabetes and cancer. Howeve...
Autores principales: | Loi, Elena M., Tomašič, Tihomir, Balsollier, Cyril, van Eekelen, Kevin, Weiss, Matjaž, Gobec, Martina, Alteen, Matthew G., Vocadlo, David J., Pieters, Roland J., Anderluh, Marko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950328/ https://www.ncbi.nlm.nih.gov/pubmed/35335358 http://dx.doi.org/10.3390/molecules27061996 |
Ejemplares similares
-
New Quinolinone O-GlcNAc Transferase Inhibitors Based on Fragment Growth
por: Weiss, Matjaž, et al.
Publicado: (2021) -
Intracellular Hydrolysis of Small-Molecule O-Linked N-Acetylglucosamine Transferase Inhibitors Differs among Cells and Is Not Required for Its Inhibition
por: Loi, Elena Maria, et al.
Publicado: (2020) -
Overview of the Assays to Probe O-Linked β-N-Acetylglucosamine Transferase Binding and Activity
por: Balsollier, Cyril, et al.
Publicado: (2021) -
C‐Terminal Tag Location Hampers in Vitro Profiling of OGT Peptide Substrates by mRNA Display
por: Shi, Jie, et al.
Publicado: (2020) -
Inhibition of O-GlcNAc Transferase Alters the Differentiation and Maturation Process of Human Monocyte Derived Dendritic Cells
por: Weiss, Matjaž, et al.
Publicado: (2021)